[Osteonecrosis after chemotherapy in children]
Related Experiment Video
Updated: Jul 8, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
B Westhoff1, M Jäger, R Krauspe
1Orthopädische Klinik, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität, Moorenstrasse 5, 40225 Düsseldorf, Deutschland.
Abstract:
The application of modern chemotherapy protocols has improved healing and survival rates significantly in pediatric malignancies. As a result, the long-term drug-related side effects are becoming increasingly apparent. Avascular osteonecrosis (AVN) occurs in up to 40% of all patients who have undergone chemotherapy, the average time of onset being 12-18 months after chemotherapy. Compared to other bones, the weight-bearing regions of hip and knee joints are most commonly affected. Incidentally and in early stages, AVN may show only mild symptoms or may not be clinical apparent. Typical risk factors for AVN after chemotherapy are the application of glucocorticoids and an age of 10 ys. and older. The etiology remains unclear. In early stages, AVN can be detected by magnetic resonance imaging (MRI). Evidence-based, standardized therapeutic concepts or orthopedic guidelines are not available for these patients to date. The range of treatment options includes several operative and non-operative treatment alternatives.
Related Concept Videos
Treatment Resistant Cancers
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Treatment Resistent Cancers
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Osteoclasts in Bone Remodeling
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...